Retinopathy of prematurity blindness worldwide: phenotypes in the third epidemic

Blindness due to retinopathy of prematurity (ROP) is an increasing problem worldwide as improved levels of neonatal care are provided in countries with developing neonatal intensive care units. The occurrence of ROP blindness varies dramatically with the socioeconomic development of a country. In regions with high levels of neonatal care and adequate resources, ROP blindness is largely restricted to premature infants with very low birth weight and low gestational age while in middle- and low-income countries with regional variation in technology and capacity, limited health resources may well limit the care of the premature newborn.

[1]  W. Tasman,et al.  Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. , 2004, Archives of ophthalmology.

[2]  J. Rahi,et al.  Severe visual impairment and blindness in children in the UK , 2003, The Lancet.

[3]  C. Gilbert.  Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control. , 2008, Early human development.

[4]  C. Bunce,et al.  Retinopathy of Prematurity in 7 Neonatal Units in Rio de Janeiro: Screening Criteria and Workload Implications , 2010, Pediatrics.

[5]  Karen W. Miller,et al.  Incidence and Early Course of Retlnonathy of Prematurity , 1991 .

[6]  Section on Ophthalmology.  Screening examination of premature infants for retinopathy of prematurity. , 2001, Pediatrics.

[7]  C. Gilbert,et al.  Retinopathy of prematurity screening and treatment cost in Brazil. , 2014, Revista panamericana de salud publica = Pan American journal of public health.

[8]  J. Lucey,et al.  A reexamination of the role of oxygen in retrolental fibroplasia. , 1984, Pediatrics.

[9]  A. Fielder,et al.  Preliminary results of treatment of eyes with high-risk prethreshold retinopathy of prematurity in the early treatment for retinopathy of prematurity randomized trial. , 2003, Archives of ophthalmology.

[10]  Michael T Trese,et al.  Evidence-based screening criteria for retinopathy of prematurity: natural history data from the CRYO-ROP and LIGHT-ROP studies. , 2002, Archives of ophthalmology.

[11]  G. Quinn,et al.  Onset of retinopathy of prematurity as related to postnatal and postconceptional age. , 1992, The British journal of ophthalmology.

[12]  A. Fielder,et al.  Preterm-associated visual impairment and estimates of retinopathy of prematurity at regional and global levels for 2010 , 2013, Pediatric Research.

[13]  William V Good,et al.  Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial. , 2004, Transactions of the American Ophthalmological Society.

[14]  B Thylefors,et al.  A global initiative for the elimination of avoidable blindness. , 1998, Community eye health.

[15]  G. Quinn,et al.  A practical method for reducing blindness due to retinopathy of prematurity in a developing country , 2012, Journal of perinatal medicine.

[16]  G. Quinn,et al.  Characteristics of Infants With Severe Retinopathy of Prematurity in Countries With Low, Moderate, and High Levels of Development: Implications for Screening Programs , 2005, Pediatrics.

[17]  K. W. Cross.  Cost of preventing retrolental fibroplasia? , 1973, Lancet.

[18]  A. Costello,et al.  Born Too Soon: Care for the preterm baby , 2013, Reproductive Health.

[19]  G. Gole,et al.  Retinopathy of prematurity-incidence today. , 2013, Clinics in perinatology.

[20]  Hans Limburg,et al.  Global initiative for the elimination of avoidable blindness , 2012 .

[21]  A R Fielder,et al.  UK retinopathy of prematurity guideline , 2009, Eye.